The estimated size of the Ebola outbreak in the Democratic Republic of the Congo has fallen by hundreds of cases as outbreak response efforts have ramped up and increased testing has ruled out illnesses.

On Tuesday, a representative for the World Health Organization confirmed to Reuters that Congolese authorities are now reporting 437 cases in the DRC, including 321 confirmed cases and 116 suspected. That's a significant difference from the case count the WHO relayed Friday, which totaled 1,041 cases, including 135 confirmed cases and 906 suspected. Over the weekend, the director-general of the Africa Centres for Disease Control and Prevention, Jean Kaseya, also wrote in an op-ed that there were more than 1,100 suspected cases.

The number of deaths has also been lowered to 48 confirmed deaths. On Friday, the WHO had reported 241 deaths, including 18 confirmed and 223 suspected.

Read full article

Comments

© Getty | Jospin Mwisha

The estimated size of the Ebola outbreak in the Democratic Republic of the Congo has fallen by hundreds of cases as outbreak response efforts have ramped up and increased testing has ruled out illnesses.

On Tuesday, a representative for the World Health Organization confirmed to Reuters that Congolese authorities are now reporting 437 cases in the DRC, including 321 confirmed cases and 116 suspected. That's a significant difference from the case count the WHO relayed Friday, which totaled 1,041 cases, including 135 confirmed cases and 906 suspected. Over the weekend, the director-general of the Africa Centres for Disease Control and Prevention, Jean Kaseya, also wrote in an op-ed that there were more than 1,100 suspected cases.

The number of deaths has also been lowered to 48 confirmed deaths. On Friday, the WHO had reported 241 deaths, including 18 confirmed and 223 suspected.

Read full article

Comments

© Getty | Jospin Mwisha

The globalists are terrified of Donald Trump getting elected for a second term because the MAGA movement is ultranationalist but the UN wants to create world citizens as opposed to national citizens. The UN intends to be the centralised global government which means a totalitarian dictatorship.

The latest global health concern, "mpox," declared a public health emergency by the WHO, has sparked fears of another orchestrated crisis by globalist powers. The rebranded disease raises suspicions of a planned "PCR-demic" for global depopulation, resonating with biblical prophecies of toxic agents as weapons of conquest and devastation.

The global health organization Coalition for Epidemic Preparedness Innovations (CEPI) announced Monday that it will "urgently accelerate development" of three vaccine candidates against Bundibugyo ebolavirus (BDBV), pledging a little over $60 million in the effort to extinguish an outbreak currently raging out of control in the Democratic Republic of the Congo.

Under the plans, CEPI has committed up to $50 million to US-based Moderna for preclinical development and Phase 1 clinical testing of its mRNA-based BDBV vaccine candidate. The funding will simultaneously allow the company to ramp up manufacturing capabilities and ready large-scale Phase 2/3 trials in the event the vaccine makes it through early testing. The vaccine will use Moderna's mRNA vaccine platform that allowed for rapid development of a COVID-19 vaccine during the pandemic.

"[W]e believe our mRNA platform can play an important role in responding rapidly to emerging infectious disease threats," Moderna CEO Stéphane Bancel said in a statement Monday. " We will move with urgency and scientific rigor to support the response and help bring a potential vaccine closer to the communities that need it most."

Read full article

Comments

© Getty | GLODY MURHABAZI

The global health organization Coalition for Epidemic Preparedness Innovations (CEPI) announced Monday that it will "urgently accelerate development" of three vaccine candidates against Bundibugyo ebolavirus (BDBV), pledging a little over $60 million in the effort to extinguish an outbreak currently raging out of control in the Democratic Republic of the Congo.

Under the plans, CEPI has committed up to $50 million to US-based Moderna for preclinical development and Phase 1 clinical testing of its mRNA-based BDBV vaccine candidate. The funding will simultaneously allow the company to ramp up manufacturing capabilities and ready large-scale Phase 2/3 trials in the event the vaccine makes it through early testing. The vaccine will use Moderna's mRNA vaccine platform that allowed for rapid development of a COVID-19 vaccine during the pandemic.

"[W]e believe our mRNA platform can play an important role in responding rapidly to emerging infectious disease threats," Moderna CEO Stéphane Bancel said in a statement Monday. " We will move with urgency and scientific rigor to support the response and help bring a potential vaccine closer to the communities that need it most."

Read full article

Comments

© Getty | GLODY MURHABAZI

As the world struggles to contain the rapidly growing Ebola outbreak in the Democratic Republic of the Congo’s Ituri Province, a vital network of research centers has been unable to help on the ground. The reason: The Trump administration slashed its funding last year, in part due to conspiracy theories about the origins of COVID-19.

Established in 2020 by the National Institutes of Health, the Centers for Research in Emerging Infectious Diseases (CREID) Network was conducting research into viruses that emerge from wildlife and spill over to people, including the family of viruses that Ebola belongs to. The network operated 10 sites around the world where these types of disease outbreaks are likely to occur, including in Central and East Africa. (The network was also researching hantavirus, a disease that saw a recent rare outbreak on a cruise ship.)

NIH provided CREID with approximately $82 million in funding over five years, and its funding was up for renewal in 2025. But last June, the centers received a stop-work order stating that their research had been deemed “unsafe for Americans and not a good use of taxpayer funding,” and that the agency’s priorities no longer supported the network.

Read full article

Comments

© Michel Lunanga / Stringer

As the world struggles to contain the rapidly growing Ebola outbreak in the Democratic Republic of the Congo’s Ituri Province, a vital network of research centers has been unable to help on the ground. The reason: The Trump administration slashed its funding last year, in part due to conspiracy theories about the origins of COVID-19.

Established in 2020 by the National Institutes of Health, the Centers for Research in Emerging Infectious Diseases (CREID) Network was conducting research into viruses that emerge from wildlife and spill over to people, including the family of viruses that Ebola belongs to. The network operated 10 sites around the world where these types of disease outbreaks are likely to occur, including in Central and East Africa. (The network was also researching hantavirus, a disease that saw a recent rare outbreak on a cruise ship.)

NIH provided CREID with approximately $82 million in funding over five years, and its funding was up for renewal in 2025. But last June, the centers received a stop-work order stating that their research had been deemed “unsafe for Americans and not a good use of taxpayer funding,” and that the agency’s priorities no longer supported the network.

Read full article

Comments

© Michel Lunanga / Stringer